Status:
ACTIVE_NOT_RECRUITING
Analgesic Potential of Light Therapy in Knee Osteoarthritis
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Osteo Arthritis Knee
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Managing joint pain is one of the main goals for treating osteoarthritis (OA) and other musculoskeletal disorders. Alleviating chronic pain pharmacologically has several potential drawbacks including ...
Detailed Description
Osteoarthritis (OA) is a progressive joint disease that affects 13% of Canadians. Managing joint pain is one of the main goals for treating OA and other musculoskeletal disorders. Alleviating chronic ...
Eligibility Criteria
Inclusion
- Osteoarthritis of the knee according to American College of Rheumatology criteria: Knee pain with 3 of the following: age \>50 years, stiffness less than 30 min, crepitus, bony tenderness, bony enlargement, no palpable warmth
- Moderate to severe pain, as defined by an average 7-day pain score of greater than 4.0 on an 11-point numerical rating scale for pain intensity (NRS-PI).
- All concurrent medications taken for any reason stable for 14 days
- Ability to follow protocol with reference to cognitive and situational factors (e.g. stable housing, ability to attend visits)
- Ability to read and write English
- Willing and able to give informed consent
Exclusion
- Currently enrolled in other clinical trial involving a pharmaceutical treatment
- Arthroscopic surgery scheduled within 8 months of study initiation
Key Trial Info
Start Date :
February 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2026
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT05398666
Start Date
February 15 2023
End Date
June 1 2026
Last Update
August 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NS Health
Halifax, Nova Scotia, Canada, B3H1V7